TD Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.5M Buy
123,323
+140
+0.1% +$17.6K 0.01% 540
2025
Q1
$13.6M Buy
123,183
+21,400
+21% +$2.37M 0.01% 576
2024
Q4
$13.9M Sell
101,783
-17,010
-14% -$2.32M 0.01% 584
2024
Q3
$13.7M Sell
118,793
-21,474
-15% -$2.47M 0.01% 589
2024
Q2
$19.3M Sell
140,267
-3,167
-2% -$436K 0.02% 503
2024
Q1
$19.8M Buy
143,434
+39,215
+38% +$5.41M 0.02% 490
2023
Q4
$13.7M Buy
104,219
+48,521
+87% +$6.39M 0.01% 562
2023
Q3
$6.27M Buy
55,698
+20,360
+58% +$2.29M 0.01% 676
2023
Q2
$3.33M Sell
35,338
-1,558
-4% -$147K ﹤0.01% 829
2023
Q1
$3.73M Sell
36,896
-1,262
-3% -$128K ﹤0.01% 817
2022
Q4
$4.56M Sell
38,158
-99,494
-72% -$11.9M 0.01% 769
2022
Q3
$14.1M Sell
137,652
-95,700
-41% -$9.83M 0.02% 494
2022
Q2
$22.7M Sell
233,352
-38,082
-14% -$3.71M 0.03% 406
2022
Q1
$25.4M Sell
271,434
-12,395
-4% -$1.16M 0.02% 425
2021
Q4
$24.2M Buy
283,829
+122,495
+76% +$10.4M 0.02% 470
2021
Q3
$15.5M Sell
161,334
-10,500
-6% -$1.01M 0.02% 536
2021
Q2
$16M Sell
171,834
-23,251
-12% -$2.17M 0.02% 535
2021
Q1
$19M Buy
195,085
+14,930
+8% +$1.45M 0.02% 479
2020
Q4
$17.3M Buy
180,155
+5,956
+3% +$571K 0.02% 463
2020
Q3
$16.8M Buy
174,199
+7,501
+4% +$721K 0.02% 426
2020
Q2
$20.3M Buy
166,698
+19,341
+13% +$2.36M 0.03% 358
2020
Q1
$12.8M Sell
147,357
-21,983
-13% -$1.9M 0.02% 424
2019
Q4
$18.2M Buy
169,340
+12,500
+8% +$1.34M 0.03% 403
2019
Q3
$14.1M Buy
156,840
+73,400
+88% +$6.61M 0.02% 435
2019
Q2
$7.05M Sell
83,440
-2,700
-3% -$228K 0.01% 607
2019
Q1
$7.59M Sell
86,140
-10,899
-11% -$960K 0.01% 587
2018
Q4
$6.93M Sell
97,039
-40,000
-29% -$2.86M 0.01% 572
2018
Q3
$16.8M Buy
137,039
+5,540
+4% +$681K 0.02% 425
2018
Q2
$12.9M Buy
131,499
+2,100
+2% +$206K 0.02% 469
2018
Q1
$10.7M Buy
129,399
+3,400
+3% +$282K 0.02% 507
2017
Q4
$9.78M Sell
125,999
-26,031
-17% -$2.02M 0.01% 526
2017
Q3
$9.32M Sell
152,030
-4,570
-3% -$280K 0.01% 526
2017
Q2
$7.2M Buy
156,600
+69,100
+79% +$3.18M 0.01% 593
2017
Q1
$3.79M Sell
87,500
-45,395
-34% -$1.97M 0.01% 764
2016
Q4
$5.14M Sell
132,895
-67,105
-34% -$2.6M 0.01% 671
2016
Q3
$10.1M Sell
200,000
-29,200
-13% -$1.48M 0.02% 524
2016
Q2
$10.4M Sell
229,200
-2,600
-1% -$118K 0.02% 501
2016
Q1
$9.17M Sell
231,800
-6,900
-3% -$273K 0.02% 519
2015
Q4
$13.5M Buy
238,700
+15,500
+7% +$877K 0.03% 416
2015
Q3
$8.88M Sell
223,200
-15,400
-6% -$613K 0.02% 488
2015
Q2
$11.4M Sell
238,600
-4,500
-2% -$215K 0.02% 472
2015
Q1
$9.65M Buy
243,100
+30,800
+15% +$1.22M 0.02% 504
2014
Q4
$4.74M Buy
212,300
+13,900
+7% +$311K 0.01% 680
2014
Q3
$3.11M Sell
198,400
-8,500
-4% -$133K 0.01% 746
2014
Q2
$3.07M Sell
206,900
-9,900
-5% -$147K 0.01% 756
2014
Q1
$3.49M Buy
216,800
+39,400
+22% +$634K 0.01% 741
2013
Q4
$1.66M Sell
177,400
-3,100
-2% -$29K ﹤0.01% 833
2013
Q3
$2.04M Buy
180,500
+34,900
+24% +$395K ﹤0.01% 798
2013
Q2
$1.95M Buy
+145,600
New +$1.95M ﹤0.01% 769